 NEWTON, Mass., May 3, 2021 PRNewswire -- Karyopharm Therapeutics Inc. Nasdaq:KPTI, a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the quarter ended March 31, 2021. 